Inventor · disambiguated record
Karen Vincent
Also filed as: VINCENT KAREN · VINCENT KAREN JANE
11 granted patents·6 pending applications·310 citations·filing 1996–2024
92Inventor score
Top patents by PatentIndex Score
17 records- 0196US9221913B2Silent Fc variants of anti-CD40 antibodiesHEUSSER CHRISTOPH·Filed 2014·Granted Dec 29, 2015·35 cites·10 claims
- 0296US8828396B2Silent Fc variants of anti-CD40 antibodiesHEUSSER CHRISTOPH·Filed 2011·Granted Sep 9, 2014·50 cites·6 claims
- 0396US6432927B1Compositions and methods for inducing gene expressionGENZYME CORP·Filed 2000·Granted Aug 13, 2002·62 cites·31 claims
- 0494US11124578B2Method of treating transplant rejection with silent Fc variants of anti-CD40 antibodiesNOVARTIS AG·Filed 2019·Granted Sep 21, 2021·6 cites·8 claims
- 0590US7053062B2Compositions and methods for inducing gene expressionGENZYME CORP·Filed 2002·Granted May 30, 2006·16 cites·24 claims
- 0688US9290573B2Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodiesCONG FENG·Filed 2011·Granted Mar 22, 2016·16 cites·9 claims
- 0787US6632670B1AAV vectors for gene therapyGENZYME CORP·Filed 1996·Granted Oct 14, 2003·119 cites·17 claims
- 0887US2024228640A9SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIESNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0983US9828433B2Nucleic acids encoding silent Fc variants of anti-CD40 antibodiesNOVARTIS AG·Filed 2017·Granted Nov 28, 2017·2 cites·8 claims
- 1079US10323096B2Nucleic acids encoding silent Fc variants of anti-CD40 antibodiesNOVARTIS AG·Filed 2017·Granted Jun 18, 2019·1 cites·8 claims
- 1178US10815497B2Production of oversized adeno-associated vectorsGENZYME CORP·Filed 2016·Granted Oct 27, 2020·2 cites·22 claims
- 1278US2022204635A1SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIESNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1375US9688768B2Silent Fc variants of anti-CD40 antibodiesHEUSSER CHRISTOPH·Filed 2015·Granted Jun 27, 2017·1 cites·10 claims
- 1467US2024392318A1Host cell lines and methods for identifying and using such host cell linesSANOFI SA·Filed 2024·Application pending·0 cites
- 1557US2006127361A1Compositions and methods for inducing gene expressionGENZYME CORP·Filed 2006·Application pending·0 cites
- 1651US2004105845A1AAV vectors for gene therapyFiled 2003·Application pending·0 cites
- 1749US2010322930A1Fibronectin-based binding molecules and their useKOLBINGER FRANK·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →